Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

被引：52

作者：

Pontali, Emanuele ^{[1
]}

D'Ambrosio, Lia ^{[2
,3
]}

Centis, Rosella ^{[2
]}

Sotgiu, Giovanni ^{[4
]}

Migliori, Giovanni Battista ^{[2
]}

机构：

[1] Galliera Hosp, Dept Infect Dis, Genoa, Italy

[2] IRCCS, WHO, Collaborating Ctr TB & Lung Dis, Maugeri Care & Res Inst, Via Roncaccio 16, I-21049 Tradate, Italy

[3] Publ Hlth Consulting Grp, Lugano, Switzerland

[4] Univ Sassari, Dept Biomed Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy

来源：

EUROPEAN RESPIRATORY JOURNAL | 2017年 / 49卷 / 03期

关键词：

MEROPENEM/CLAVULANATE-CONTAINING REGIMENS; COMPASSIONATE USE; ATP SYNTHASE; MDR-TB; SAFETY; DELAMANID; EFFICACY; CHILDREN; FLUOROQUINOLONES; TOLERABILITY;

D O I：

10.1183/13993003.00146-2017

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页数：8

共 75 条

[1]

Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease [J].

Alexander, David C. ;

Vasireddy, Ravikiran ;

Vasireddy, Sruthi ;

Philley, Julie V. ;

Brown-Elliott, Barbara A. ;

Perry, Benjamin J. ;

Griffith, David E. ;

Benwill, Jeana L. ;

Cameron, Andrew D. S. ;

Wallace, Richard J., Jr. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (02) :574-584

[2]

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].

Andries, K ;

Verhasselt, P ;

Guillemont, J ;

Göhlmann, HWH ;

Neefs, JM ;

Winkler, H ;

Van Gestel, J ;

Timmerman, P ;

Zhu, M ;

Lee, E ;

Williams, P ;

de Chaffoy, D ;

Huitric, E ;

Hoffner, S ;

Cambau, E ;

Truffot-Pernot, C ;

Lounis, N ;

Jarlier, V .

SCIENCE, 2005, 307 (5707) :223-227

[3]

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline [J].

Andries, Koen ;

Villellas, Cristina ;

Coeck, Nele ;

Thys, Kim ;

Gevers, Tom ;

Vranckx, Luc ;

Lounis, Nacer ;

de Jong, Bouke C. ;

Koul, Anil .

PLOS ONE, 2014, 9 (07)

[4]

[Anonymous], EMERG INFECT DIS

[5]

[Anonymous], 2014, USE DELAMANID TREATM

[6]

Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study [J].

Bonnet, M. ;

Bastard, M. ;

du Cros, P. ;

Khamraev, A. ;

Kimenye, K. ;

Khurkhumal, S. ;

Hayrapetyan, A. ;

Themba, D. ;

Telnov, A. ;

Sanchez-Padilla, E. ;

Hewison, C. ;

Varaine, F. .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (02) :177-186

[7]

Brill MJ, 2016, INT J ANTIMICROB AG

[8]

In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex [J].

Brown-Elliott, Barbara A. ;

Philley, Julie V. ;

Griffith, David E. ;

Thakkar, Foram ;

Wallace, Richard J., Jr. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)

[9]

The experience of bedaquiline implementation at a decentralised clinic in South Africa [J].

Cariem, R. ;

Cox, V. ;

de Azevedo, V. ;

Hughes, J. ;

Mohr, E. ;

Duran, L. Trivino ;

Ndjeka, N. ;

Furin, J. .

PUBLIC HEALTH ACTION, 2016, 6 (03) :190-192

[10]

Tuberculosis elimination: theory and practice in Europe [J].

D'Ambrosio, Lia ;

Dara, Masoud ;

Tadolin, Marina ;

Centis, Rosella ;

Sotgiu, Giovanni ;

van der Werf, Marieke J. ;

Gaga, Mina ;

Cirillo, Daniela ;

Spanevello, Antonio ;

Raviglione, Mario ;

Blasi, Francesco ;

Migliori, Giovanni Battista .

EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) :1410-1420

← 1 2 3 4 5 6 7 8 →